Home › T-Cell Lymphoma › Texas › Houston
T-Cell Lymphoma clinical trials in Houston, TX
8 studies for T-Cell Lymphoma are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
RecruitingPhase 3
- MD Anderson Cancer Center, Houston
Phase 1 Study of JV-394 Autologous Anti-CD94 CAR T for r/r CD94+ T/NK Cell Neoplasms
RecruitingPhase 1
- The University of Texas M. D. Anderson Cancer Center, Houston
CD4CAR for CD4+ Leukemia and Lymphoma
RecruitingPhase 1
- The University of Texas MD Anderson Cancer Center, Houston
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RecruitingObservational study
- Texas Children's Hospital, Houston
A Registry for People With T-cell Lymphoma
RecruitingObservational study
- MD Anderson Cancer Center (Data Collection Only), Houston
MB-105 in Patients With CD5 Positive T-cell Lymphoma
RecruitingPhase 2
- Baylor College of Medicine, Houston
- MD Anderson Cancer Center, Houston
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
RecruitingPhase 1
- The University of Texas MD Anderson Cancer Center, Houston
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RecruitingPhase 1
- Texas Children's Hospital/Baylor College of Medicine, Houston
T-Cell Lymphoma trials in other cities
- New York City, NY13 studies
- Philadelphia, PA10 studies
- Baldwin Park, CA9 studies
- Boston, MA9 studies
- Atlanta, GA7 studies
- Seattle, WA6 studies
- Columbus, OH6 studies
- Rochester, MN6 studies
- Chicago, IL6 studies
- New Haven, CT5 studies
- Miami, FL5 studies
- Charlottesville, VA4 studies
Other studies in Houston
- Non-Small Cell Lung Cancer145 studies
- Breast Cancer126 studies
- Cancer (all types)122 studies
- Metastatic Cancer104 studies
- Colorectal Cancer103 studies
- Ovarian Cancer90 studies
- Acute Myeloid Leukemia86 studies
- Lung Cancer78 studies
- Prostate Cancer76 studies
- Endometrial Cancer69 studies
- Pancreatic Cancer62 studies
- Melanoma59 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.